Gonadorelin — Safety, Research, Risks & Legal Status

Not medical advice. Gonadorelin is discussed here for informational and harm-reduction purposes only. We do not endorse use, and any dosing context is informational, not a protocol.

Also known as	GnRH, LHRH, fertagyl (pharmaceutical)
Category	Peptide
LH	Luteinizing hormone; stimulates testosterone production in males and ovulation in females
FSH	Follicle-stimulating hormone; supports spermatogenesis in males and follicle development in females
pituitary	Pea-sized gland at base of brain; anterior pituitary releases LH and FSH in response to GnRH
US legal status	FDA-approved for medical use (reproductive disorders, pituitary testing, delayed puberty); available by prescription as Factrel or Lutrepulse; research-chemical versions sold online are not regulated; prescription forms are pharmaceutical-grade

What is Gonadorelin?

10-amino acid gonadotropin-releasing hormone (GnRH) that stimulates LH and FSH production; established medical use for fertility and hormone regulation; research into HPA-axis recovery and fertility in males ongoing. GnRH is released pulsatilely from the hypothalamus; dosing route and frequency determine whether it stimulates or suppresses the reproductive axis.

How it works

GnRH binds to GnRH receptors on gonadotropin-releasing cells in the anterior pituitary. Pulsatile GnRH (every 60-90 minutes) stimulates LH and FSH release; continuous GnRH agonists desensitize receptors, suppressing LH and FSH. The frequency and duration of GnRH exposure determine whether the reproductive axis is activated or inhibited.

Background & history

GnRH was discovered and synthesized in the 1970s, earning a Nobel Prize. Medical applications in fertility emerged immediately. Pulsatile GnRH therapy (Lutrepulse) treats hypogonadotropic hypogonadism; continuous GnRH agonists (for cancer and endometriosis) followed. Off-label interest in steroid recovery and male fertility expanded in recent decades.

What the research says

Strong clinical data in OB/GYN and endocrinology contexts; some evidence for male fertility support; studied in pulsatile or continuous protocols with different effects. Pulsatile GnRH restores fertility; continuous GnRH agonists suppress testosterone and are used for prostate cancer and endometriosis. Off-label use for anabolic steroid recovery is explored but not formally validated.

Reported effects

Established medical use for ovulation induction and testicular stimulation
GnRH agonists in continuous dosing suppress testosterone (used in prostate cancer)
Pulsatile dosing restores fertility in hypogonadal males
Studied to reverse suppression from anabolic steroid use (off-label research)
May support HPA-axis function and normalize hormone rhythms in specific contexts

Dosing & administration (informational)

Pharmaceutical pulsatile therapy (Lutrepulse pump): 5-20 microgram pulses every 90 minutes. Medical bolus doses for testing: 100 microgram IV. Underground male fertility and steroid recovery protocols cite 100-500 microgram subcutaneous, often daily or several times weekly; highly unvalidated and variable.

This is general research/context information, not medical advice or a recommended protocol.

Safety & side effects

Pharmaceutical gonadorelin is safe for approved medical uses under MD supervision
Research-chemical gonadorelin from online sources varies in purity, sterility, and authenticity; carries injection infection risks
Short-term side effects: headache, local reaction at injection site, minor hormonal shifts if used acutely
Long-term off-label effects unknown; testosterone suppression or overstimulation depends on dosing protocol and individual response
Pregnancy: FDA Category C (approved forms); breastfeeding minimal data
Misuse for steroid recovery without medical monitoring carries risk of inadequate HPA-axis recovery

Drug & supplement interactions

GnRH agonists suppress testosterone; combination with anabolic steroids is contradictory and not studied
Dopamine agonists (bromocriptine): may modulate prolactin and GnRH; interaction unclear
Estrogen or progesterone therapies may alter GnRH sensitivity; overlap in fertility contexts
Psychotropic drugs (antipsychotics, SSRIs): may affect GnRH or prolactin; not well-characterized

Who should avoid it

Pregnancy and lactation (GnRH agonists suppress reproductive hormones)
Undiagnosed pituitary or hypothalamic disease
Active prostate cancer on GnRH agonist therapy (would interfere with oncology regimen)
Severe osteoporosis (continuous GnRH agonists reduce bone density; pulsatile is safer)
Concurrent use of anabolic steroids for performance enhancement

How it is commonly combined

Pulsatile GnRH is sometimes combined with human chorionic gonadotropin (hCG) or FSH for male fertility; this is medically validated. Off-label steroid recovery combinations with aromatase inhibitors and SERMs are attempted informally but carry risk of inadequate recovery.

Legal & regulatory. FDA-approved for medical use (reproductive disorders, pituitary testing, delayed puberty); available by prescription as Factrel or Lutrepulse; research-chemical versions sold online are not regulated; prescription forms are pharmaceutical-grade

Quality & harm reduction

P
h
a
r
m
a
c
e
u
t
i
c
a
l
F
a
c
t
r
e
l
o
r
L
u
t
r
e
p
u
l
s
e
:
F
D
A
-
a
p
p
r
o
v
e
d
;
g
u
a
r
a
n
t
e
e
d
p
u
r
i
t
y
a
n
d
s
t
e
r
i
l
i
t
y
.
R
e
s
e
a
r
c
h
-
c
h
e
m
i
c
a
l
g
o
n
a
d
o
r
e
l
i
n
:
t
h
i
r
d
-
p
a
r
t
y
C
O
A
,
H
P
L
C
9
8
%
+
p
u
r
i
t
y
,
m
a
s
s
s
p
e
c
c
o
n
f
i
r
m
a
t
i
o
n
,
e
n
d
o
t
o
x
i
n
l
e
s
s
t
h
a
n
0
.
2
5
I
U
/
k
g
.
R
e
f
r
i
g
e
r
a
t
e
2
-
8
°
C
;
f
r
e
e
z
e
s
t
a
b
l
e
a
t
-
2
0
°
C
;
s
i
n
g
l
e
-
u
s
e
s
t
e
r
i
l
e
v
i
a
l
s
o
n
l
y
;
s
o
m
e
f
o
r
m
u
l
a
t
i
o
n
s
a
r
e
m
o
r
e
s
t
a
b
l
e
t
h
a
n
o
t
h
e
r
s
.
I
f
s
o
u
r
c
e
d
o
n
l
i
n
e
,
v
e
r
i
f
y
l
a
b
a
c
c
r
e
d
i
t
a
t
i
o
n
;
c
o
n
t
a
m
i
n
a
t
i
o
n
i
n
i
n
j
e
c
t
a
b
l
e
p
e
p
t
i
d
e
s
c
a
n
c
a
u
s
e
s
e
r
i
o
u
s
i
n
f
e
c
t
i
o
n
.

Safer, legal alternative we recommend

Sleep optimization, stress reduction, and whole-food nutrition. Proper sleep, low cortisol, and adequate micronutrients (zinc, vitamin D) naturally support healthy testosterone and reproductive hormone balance without injection or pharmaceutical risk.

See our recommended pick

Lab testing & harm-reduction tools

If you are going to research a compound, verifying identity and purity is the single most protective step. Independent analytical testing and sterile-handling supplies reduce risk.

Compare testing options

Frequently asked questions

Is prescription gonadorelin (Factrel) the same as online research chemical versions?

Factrel is pharmaceutical and FDA-approved; online compounds are unregulated and variable. Pharmaceutical is vastly safer.

Can gonadorelin reverse testosterone suppression from steroids?

Pulsatile GnRH can stimulate LH/FSH production, potentially supporting recovery; used off-label in research and by sports physicians. Effects are individual and not guaranteed.

What happens if I inject too much?

Acute GnRH overdose typically causes transient hormone surge; chronic overdose or continuous dosing suppresses testosterone. Dosing errors carry real risks.

Can women use gonadorelin safely?

Yes, under medical supervision for fertility; pulsatile protocols are standard. Off-label or improper use can cause irregular ovulation or ovarian hyperstimulation.

Is GnRH the same as GnRH agonists?

No. GnRH is the natural hormone; GnRH agonists are synthetic analogs that cause initial stimulation then desensitization leading to suppression.

References & further reading

GnRH biology and pituitary function: Endocrinology and Neuroendocrinology journals
GnRH agonists in cancer therapy: Oncology and Urology literature
Fertility and reproductive endocrinology: OB/GYN and fertility medicine textbooks
Male hypogonadism and gonadotropin therapy: Journal of Andrology and Andrology journals
HPA-axis recovery and anabolic steroid cessation: specialized sports medicine and endocrinology literature